Cargando…

Expression and network analysis of YBX1 interactors for identification of new drug targets in lung adenocarcinoma

Y-Box Binding protein 1 (YBX-1) is known to be involved in various types of cancers. It's interactors also play major role in various cellular functions. Present work aimed to study the expression profile of the YBX-1 interactors during lung adenocarcinoma (LUAD). The differential expression an...

Descripción completa

Detalles Bibliográficos
Autores principales: Murugesan, Suriya Narayanan, Yadav, Birendra Singh, Maurya, Pramod Kumar, Chaudhary, Amit, Singh, Swati, Mani, Ashutosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030768/
https://www.ncbi.nlm.nih.gov/pubmed/29973960
http://dx.doi.org/10.7150/jgen.20581
_version_ 1783337189671698432
author Murugesan, Suriya Narayanan
Yadav, Birendra Singh
Maurya, Pramod Kumar
Chaudhary, Amit
Singh, Swati
Mani, Ashutosh
author_facet Murugesan, Suriya Narayanan
Yadav, Birendra Singh
Maurya, Pramod Kumar
Chaudhary, Amit
Singh, Swati
Mani, Ashutosh
author_sort Murugesan, Suriya Narayanan
collection PubMed
description Y-Box Binding protein 1 (YBX-1) is known to be involved in various types of cancers. It's interactors also play major role in various cellular functions. Present work aimed to study the expression profile of the YBX-1 interactors during lung adenocarcinoma (LUAD). The differential expression analysis involved 57 genes from 95 lung adenocarcinoma samples, construction of gene network and topology analysis. A Total of 43 genes were found to be differentially expressed from which 17 genes were found to be down regulated and 26 genes were up-regulated. We observed that Polyadenylate-binding protein 1 (PABPC1), a protein involved in YBX1 translation, is highly correlated with YBX1. The interaction network analysis for a differentially expressed non-coding RNA Growth Arrest Specific 5 (GAS5) suggests that two proteins namely, Growth Arrest Specific 2 (GAS2) and Peripheral myelin protein 22 (PMP22) are potentially involved in LUAD progression. The network analysis and differential expression suggests that Collagen type 1 alpha 2 (COL1A2) can be potential biomarker and target for LUAD.
format Online
Article
Text
id pubmed-6030768
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-60307682018-07-04 Expression and network analysis of YBX1 interactors for identification of new drug targets in lung adenocarcinoma Murugesan, Suriya Narayanan Yadav, Birendra Singh Maurya, Pramod Kumar Chaudhary, Amit Singh, Swati Mani, Ashutosh J Genomics Research Paper Y-Box Binding protein 1 (YBX-1) is known to be involved in various types of cancers. It's interactors also play major role in various cellular functions. Present work aimed to study the expression profile of the YBX-1 interactors during lung adenocarcinoma (LUAD). The differential expression analysis involved 57 genes from 95 lung adenocarcinoma samples, construction of gene network and topology analysis. A Total of 43 genes were found to be differentially expressed from which 17 genes were found to be down regulated and 26 genes were up-regulated. We observed that Polyadenylate-binding protein 1 (PABPC1), a protein involved in YBX1 translation, is highly correlated with YBX1. The interaction network analysis for a differentially expressed non-coding RNA Growth Arrest Specific 5 (GAS5) suggests that two proteins namely, Growth Arrest Specific 2 (GAS2) and Peripheral myelin protein 22 (PMP22) are potentially involved in LUAD progression. The network analysis and differential expression suggests that Collagen type 1 alpha 2 (COL1A2) can be potential biomarker and target for LUAD. Ivyspring International Publisher 2018-06-26 /pmc/articles/PMC6030768/ /pubmed/29973960 http://dx.doi.org/10.7150/jgen.20581 Text en © Ivyspring International Publisher This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Murugesan, Suriya Narayanan
Yadav, Birendra Singh
Maurya, Pramod Kumar
Chaudhary, Amit
Singh, Swati
Mani, Ashutosh
Expression and network analysis of YBX1 interactors for identification of new drug targets in lung adenocarcinoma
title Expression and network analysis of YBX1 interactors for identification of new drug targets in lung adenocarcinoma
title_full Expression and network analysis of YBX1 interactors for identification of new drug targets in lung adenocarcinoma
title_fullStr Expression and network analysis of YBX1 interactors for identification of new drug targets in lung adenocarcinoma
title_full_unstemmed Expression and network analysis of YBX1 interactors for identification of new drug targets in lung adenocarcinoma
title_short Expression and network analysis of YBX1 interactors for identification of new drug targets in lung adenocarcinoma
title_sort expression and network analysis of ybx1 interactors for identification of new drug targets in lung adenocarcinoma
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030768/
https://www.ncbi.nlm.nih.gov/pubmed/29973960
http://dx.doi.org/10.7150/jgen.20581
work_keys_str_mv AT murugesansuriyanarayanan expressionandnetworkanalysisofybx1interactorsforidentificationofnewdrugtargetsinlungadenocarcinoma
AT yadavbirendrasingh expressionandnetworkanalysisofybx1interactorsforidentificationofnewdrugtargetsinlungadenocarcinoma
AT mauryapramodkumar expressionandnetworkanalysisofybx1interactorsforidentificationofnewdrugtargetsinlungadenocarcinoma
AT chaudharyamit expressionandnetworkanalysisofybx1interactorsforidentificationofnewdrugtargetsinlungadenocarcinoma
AT singhswati expressionandnetworkanalysisofybx1interactorsforidentificationofnewdrugtargetsinlungadenocarcinoma
AT maniashutosh expressionandnetworkanalysisofybx1interactorsforidentificationofnewdrugtargetsinlungadenocarcinoma